Does DULAGLUTIDE Cause Pancreatic carcinoma? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Pancreatic carcinoma have been filed in association with DULAGLUTIDE (Trulicity). This represents 0.3% of all adverse event reports for DULAGLUTIDE.
229
Reports of Pancreatic carcinoma with DULAGLUTIDE
0.3%
of all DULAGLUTIDE reports
51
Deaths
64
Hospitalizations
How Dangerous Is Pancreatic carcinoma From DULAGLUTIDE?
Of the 229 reports, 51 (22.3%) resulted in death, 64 (27.9%) required hospitalization, and 25 (10.9%) were considered life-threatening.
Is Pancreatic carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULAGLUTIDE. However, 229 reports have been filed with the FAERS database.
What Other Side Effects Does DULAGLUTIDE Cause?
Injection site pain (9,474)
Nausea (9,137)
Blood glucose increased (9,119)
Incorrect dose administered (5,207)
Diarrhoea (5,036)
Vomiting (4,880)
Inappropriate schedule of product administration (3,606)
Extra dose administered (3,047)
Injection site haemorrhage (3,028)
Weight decreased (3,000)
What Other Drugs Cause Pancreatic carcinoma?
RANITIDINE (15,752)
SITAGLIPTIN (1,142)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (838)
EXENATIDE (781)
LIRAGLUTIDE (680)
METFORMIN\SITAGLIPTIN (431)
PACLITAXEL (325)
SEMAGLUTIDE (237)
ADALIMUMAB (213)
JANUVIA (185)
Which DULAGLUTIDE Alternatives Have Lower Pancreatic carcinoma Risk?
DULAGLUTIDE vs DULERA
DULAGLUTIDE vs DULOXETINE
DULAGLUTIDE vs DUPILUMAB
DULAGLUTIDE vs DURAGESIC
DULAGLUTIDE vs DUROGESIC